BMYMP Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own BMYMP shares is N/A, representing N/A of the company's common stock.

N/A, in the last quarter, reduced its stake in BMYMP by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the BMYMP shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned BMYMP shares holding by N/A last quarter which brought its holding to - shares worth -.

As per its latest 13F filing, N/A increased its stake in BMYMP by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of BMYMP to its portfolio, raising its holding to - shares of worth -. N/A also increased its BMYMP shares holding by N/A which brought its holding to - shares worth -.

The insider with the most stakes in BMYMP is Caforio Giovanni , Board Chair and CEO at the company. Additionally, BMYMP stock is highly held by Chief Executive Officer BOERNER CHRISTOPHER S. and EVP & President, Research VESSEY RUPERT among others.

Company executives, directors, and other insiders own N/A percent of Bristol-Myers Squibb Company PFD CONV 2's stock. Within the last six months, there have been 0 transaction(s) in which BMYMP insiders have sold stock, totaling 0 shares. Insiders that have sold shares include POWELL ANN, PLENGE ROBERT M, and VESSEY RUPERT.

There have been 0 transaction(s) during the past 6-months in which Bristol-Myers Squibb Company PFD CONV 2 insiders have bought stock, totalling 0 shares

Around 0 Bristol-Myers Squibb Company PFD CONV 2 shares are held by insiders, which represents about N/A of BMYMP stock.

BMYMP Board Chair and CEO, Caforio Giovanni holds the largest portfolio of the company's shares. BMYMP shares owned by Caforio total nearly 236.1 thousand.

N/A is the largest institutional owner in BMYMP which holds - shares worth - or N/A of the total BMYMP shares outstanding followed by N/A with ownership of - shares representing N/A of the BMYMP ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the BMYMP is concerned, it is a stock which is optionable.

Number of BMYMP shares short is N/A. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, N/A shares of BMYMP are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, BMYMP has N/A shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for BMYMP is N/A.